|
Volumn 19, Issue 3, 2002, Pages 190-192
|
Advances, challenges, and controversies in poisoning
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3,4 METHYLENEDIOXYMETHAMPHETAMINE;
4 HYDROXYBUTYRIC ACID;
4 METHYLPYRAZOLE;
ACETYLCYSTEINE;
ACETYLSALICYLIC ACID;
ACTIVATED CARBON;
ALCOHOL;
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE DERIVATIVE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BICARBONATE;
CARBON MONOXIDE;
COCAINE;
DEFEROXAMINE;
ECSTACY;
ETHYLENE GLYCOL;
METHANOL;
NITRATE;
PARACETAMOL;
SALICYLIC ACID DERIVATIVE;
SILDENAFIL;
BIOLOGICAL WARFARE;
BODY WEIGHT;
CARBON MONOXIDE INTOXICATION;
CARDIOVASCULAR DISEASE;
CLINICAL MEDICINE;
CLINICAL TRIAL;
DISEASE SEVERITY;
DRUG BLOOD LEVEL;
DRUG COST;
DRUG ELIMINATION;
DRUG INTOXICATION;
DRUG MISUSE;
DRUG OVERDOSE;
DRUG TOLERABILITY;
EDITORIAL;
EMERGENCY WARD;
EVIDENCE BASED MEDICINE;
HEMODIALYSIS;
HEMOFILTRATION;
HUMAN;
HYPERBARIC OXYGEN;
MEDICAL INFORMATION;
MEDICAL RESEARCH;
METHANOL POISONING;
PATIENT CARE;
PRACTICE GUIDELINE;
SELF POISONING;
TOXICOLOGY;
|
EID: 0036274289
PISSN: 13510622
EISSN: None
Source Type: Journal
DOI: 10.1136/emj.19.3.190 Document Type: Editorial |
Times cited : (6)
|
References (26)
|